文献速递类风湿关节炎

HLA共享表位与吸烟在类风湿关节炎不同临床前期阶段的作用

Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2021-07-20

该研究通过荟萃分析与队列随访,探讨HLA共享表位(HLA-SE)和吸烟在RA临床前期各阶段的作用。结果显示吸烟与无症状人群ACPA阳性及症状发展相关,而HLA-SE主要与症状出现后及临床关节炎进展相关。

要点

  • 吸烟在无症状阶段即与ACPA阳性相关,HLA-SE则无关。
  • HLA-SE与ACPA阳性关节痛患者进展为临床关节炎风险相关。
  • 吸烟与症状发展相关,但不影响进展为临床关节炎。

核心结论

  • HLA-SE和吸烟在RA不同临床前期阶段发挥作用:吸烟增加ACPA和症状发生风险,HLA-SE介导症状和临床关节炎进展。

研究设计与样本

  • 对文献中HLA-SE和吸烟与无症状人群ACPA关联进行荟萃分析,并在ACPA阳性CSA患者中验证关联,随访进展至临床炎症性关节炎。

主要发现

  • 无症状人群中HLA-SE与ACPA阳性无关(OR 1.06,95%CI 0.69-1.64),吸烟与ACPA阳性相关(OR 1.37,95%CI 1.15-1.63)。
  • CSA起病时HLA-SE和吸烟均与ACPA阳性相关(OR 2.08,95%CI 1.24-3.49;OR 2.41,95%CI 1.31-4.43)。
  • 随访中HLA-SE与临床关节炎发展相关(HR 1.86,95%CI 1.23-2.82),吸烟无此关联;ACPA阳性关节痛荟萃分析证实HLA-SE关联(HR 1.52,95%CI 1.08-2.15)。
  • HLA-SE和吸烟与CSA起病时RF、anti-CarP或AAPA阳性无关。
  • 纵向分析中AAPA与临床关节炎发展独立相关(HR 1.79,95%CI 1.02-3.16),anti-CarP无此关联。

临床怎么用

  • 对于ACPA阳性关节痛患者,HLA-SE检测可能有助于识别进展为临床关节炎的高风险个体。
  • 吸烟史应作为RA临床前期风险评估的参考因素,尤其关注ACPA和症状发展。

局限性

  • 研究基于文献荟萃分析和队列随访,未报告原始样本量及具体随访时长等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking are the most prominent genetic and environmental risk factors for rheumatoid arthritis (RA). However, at which pre-arthritis stage (asymptomatic/symptomatic) they exert their effect is unknown. We aimed to determine whether HLA-SE and smoking are involved in the onset of autoantibody positivity, symptoms (clinically suspect arthralgia (CSA)) and/or progression to clinical arthritis. METHODS: We performed meta-analyses on results from the literature on associations of HLA-SE and smoking with anti-citrullinated protein antibodies (ACPAs) in the asymptomatic population. Next, we studied associations of HLA-SE and smoking with autoantibody positivity at CSA onset and with progression to clinical inflammatory arthritis (IA) during follow-up. Associations in ACPA-positive patients with CSA were validated in meta-analyses with other arthralgia cohorts. Analyses were repeated for rheumatoid factor (RF), anti-carbamylated protein antibodies (anti-CarP) and anti-acetylated protein antibodies (AAPA). RESULTS: Meta-analyses showed that HLA-SE is not associated with ACPA positivity in the asymptomatic population (OR 1.06 (95% CI:0.69 to 1.64)), whereas smoking was associated (OR 1.37 (95% CI: 1.15 to 1.63)). At CSA onset, both HLA-SE and smoking associated with ACPA positivity (OR 2.08 (95% CI: 1.24 to 3.49), OR 2.41 (95% CI: 1.31 to 4.43)). During follow-up, HLA-SE associated with IA development (HR 1.86 (95% CI: 1.23 to 2.82)), in contrast to smoking. This was confirmed in meta-analyses in ACPA-positive arthralgia (HR 1.52 (95% CI: 1.08 to 2.15)). HLA-SE and smoking were not associated with RF, anti-CarP or AAPA-positivity at CSA onset. Longitudinally, AAPA associated with IA development independent from ACPA and RF (HR 1.79 (95% CI: 1.02 to 3.16)), anti-CarP did not. CONCLUSIONS: HLA-SE and smoking act at different stages: smoking confers risk for ACPA and symptom development, whereas HLA-SE mediates symptom and IA development. These data enhance the understanding of the timing of the key risk factors in the development of RA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Wouters F, Maurits MP, van Boheemen L, et al. Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis. Ann Rheum Dis. 2021. PMID: 34285049. doi:10.1136/annrheumdis-2021-220546

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。